Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients-Reference-Cited by-同舟云学术

Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients

Published:2017-03-09 Issue:10 Volume:140 Page:2344-2350
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Cheng He¹²³,Liu Chen¹²³,Jiang Jiahao¹²³,Luo Guopei¹²³,Lu Yu¹²³,Jin Kaizhou¹²³,Guo Meng¹²³,Zhang Zhenzhen⁴,Xu Jin¹²³,Liu Liang¹²³,Ni Quanxing¹²³,Yu Xianjun¹²³^ORCID

Affiliation:

1. Department of Pancreatic Surgery; Fudan University Shanghai Cancer Center; No. 270 DongAn Road Shanghai 200032 People's Republic of China

2. Department of Oncology; Shanghai Medical College, Fudan University; No. 270 DongAn Road Shanghai 200032 People's Republic of China

3. Pancreatic Cancer Institute, Fudan University; No. 270 DongAn Road Shanghai 200032 People's Republic of China

4. Zhangjiang Center for Translational Medicine; Shanghai 200120 People's Republic of China

Funder

National Natural Science Foundation of China

Shanghai Municipal Commission of Health and Family Planning scientific research project

Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference36 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Adjuvant therapy for pancreatic cancer: a review;Zuckerman;Cancer,2008

3. Combinational therapy: new hope for pancreatic cancer?;Shi;Cancer Lett,2012

4. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer;Tempero;Cancer Res,1987

5. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions;Marrelli;Am J Surg,2009

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast progressing patients;Translational Research;2024-09

2. Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies;Cancers;2024-07-01

3. Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers;ACS Biomaterials Science & Engineering;2024-07-01

4. High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study;Journal of Translational Medicine;2024-02-20

5. Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer;Journal of Cancer Research and Clinical Oncology;2024-01-26